Tumor Necrosis Factor-Alpha (TNF-α) Gene Expression in Chronic Hepatitis B Virus Infection

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The Egyptian Journal of Hospital Medicine

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.12816/0013791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus infection

  2015cited by this paper
• [Infectious diseases].

  2014cited by this paper
• Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy.

  2013cited by this paper
• Living in the liver: hepatic infections

  2012cited by this paper
• The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection

  2012cited by this paper
• Association between TNF-α promoter G-308A and G-238A polymorphisms and obesity

  2011cited by this paper
• Relationship between TNF- Gene Promoter Polymorphisms and Outcomes of Hepatitis B Virus Infections: A Meta-Analysis

  2011cited by this paper
• Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population

  2010cited by this paper
• The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection

  2010cited by this paper
• Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations.

  2010cited by this paper
• Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective

  2008influential reference
• Tumor Necrosis Factor Activates a Conserved Innate Antiviral Response to Hepatitis B Virus That Destabilizes Nucleocapsids and Reduces Nuclear Viral DNA

  2007cited by this paper
• Immunobiology and pathogenesis of viral hepatitis.

  2006cited by this paper
• Tumor Necrosis Factor–α Promoter Polymorphism at Position −308 Predicts Response to Combination Therapy in Hepatitis C Virus Infection

  2006cited by this paper
• Association of TNF‐alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population

  2006cited by this paper
• Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B.

  2006cited by this paper
• Association between chronic hepatitis B virus infection and interleukin‐10, tumor necrosis factor‐α gene promoter polymorphisms

  2006cited by this paper
• Global challenges in liver disease

  2006cited by this paper
• TNF-α, chronic hepatitis C and diabetes: a novel triad

  2005cited by this paper
• Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.

  2005cited by this paper
• Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection

  2005cited by this paper
• A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.

  2004cited by this paper
• Hepatitis C virus mutation affects proteasomal epitope processing.

  2004cited by this paper
• Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis

  2004cited by this paper
• Nitric oxide and pro-inflammatory cytokines in acute hepatitis B.

  2004cited by this paper
• TNFα Promoter Polymorphisms

  2004cited by this paper
• Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal

  2003cited by this paper
• Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome.

  2002cited by this paper
• Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus

  2002cited by this paper
• TNF-α promoter single nucleotide polymorphisms are markers of human ancestry

  2002cited by this paper
• Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection

  2001cited by this paper
• Differential CD4+ and CD8+ T‐cell responsiveness in hepatitis C virus infection

  2001cited by this paper
• Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection

  2000cited by this paper
• Chronic viral hepatitis and the human genome

  2000cited by this paper
• Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene.

  1999cited by this paper
• La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA

  1999cited by this paper
• Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence

  1999cited by this paper
• Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

  1999cited by this paper
• Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

  1999cited by this paper
• Relationship Among Hepatic Inflammatory Changes, Circulating Levels of Cytokines, and Response to IFN-α in Chronic Hepatitis C

  1998cited by this paper
• A tumour necrosis factor‐alpha (TNF‐α) promoter polymorphism is associated with chronic hepatitis B infection

  1998cited by this paper
• Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

  1997cited by this paper
• The −308 tumor necrosis factor-α promoter polymorphism effects transcription

  1997cited by this paper
• Cytokine gene expression in cirrhotic and non-cirrhotic human liver.

  1996cited by this paper
• Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C

  1996cited by this paper
• Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo

  1996cited by this paper
• Cytokines in the generation of immune responses to, and resolution of, virus infection.

  1994cited by this paper
• Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope

  1994cited by this paper
• An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles

  1993cited by this paper
• Hepatitis B vaccine recombinant

  1992cited by this paper
• Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.

  1992cited by this paper
• Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene

  1991cited by this paper
• Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

  1991cited by this paper
• Two distinct types of hepatitis in experimental hepatitis B virus infection.

  1980cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• No citing papers are available for this paper.